her2-neu

Affibody (affibody) ligands that are specific for the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) have been selected by phage display technology from a combinatorial protein library based on the 58 amino acid residue staphy

HER2 neu (654-662) GP2 acetate is derived from the human epidermal growth factor receptor 2 (HER2-Neu, 654–662). HER2 neu (654-662) GP2 acetate induces HLA-A2-restricted cytotoxic T lymphocytes reactive to various epithelial cancers.

TYVPANASL TFA, a nine-amino-acid MHC I-binding CD8 T-cell epitope derived from HER2 neu, is utilized in the formulation of J-LEAPS vaccines [1].

TYVPANASL, a nine-amino-acid MHC I-binding epitope from HER2 neu for CD8 T cells, can be utilized in the development of J-LEAPS vaccines [1].

SPPHPSPAFSPAFDNLYYWDQ TFA is a multi-epitope, class II rat HER2 neu peptide designed for research on the class II HER2-DC1 vaccine [1].

SPPHPSPAFSPAFDNLYYWDQ is a multi-epitope class II rat HER2 neu peptide used in the investigation of class II HER2-DC1 vaccine studies [1].

IRGRILHDGAYSLTLQGLGIH TFA, a multi-epitope class II rat HER2 neu peptide, is utilized in the study of class II HER2-DC1 vaccines [1].

IRGRILHDGAYSLTLQGLGIH is a multi-epitope class II rat HER2 neu peptide used in HER2-DC1 vaccine research studies [1].

ELAAWCRWGFLLALLPPGIAG TFA (P5), a 21-amino-acid peptide (aa 5-25) originating from the rat HER2 neu protein, has been shown to elicit cytotoxic T lymphocyte (CTL) responses in mice with HER2-positive tumors [1].

ELAAWCRWGFLLALLPPGIAG (P5), a 21-amino acid peptide (aa 5-25) derivative of the rat HER2 neu protein, has been shown to elicit cytotoxic T lymphocyte (CTL) responses in mice with HER2-positive tumors [1].